138 related articles for article (PubMed ID: 27349720)
1. PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression.
Yang W; Li Y; Li P; Wang L
Oncol Rep; 2016 Aug; 36(2):1069-75. PubMed ID: 27349720
[TBL] [Abstract][Full Text] [Related]
2. Arsenic disulfide induces apoptosis of human diffuse large B cell lymphoma cells involving Bax cleavage.
Wang L; Liu X; Li X; Lv X; Lu K; Chen N; Li P; Wang X
Oncol Rep; 2013 Nov; 30(5):2427-34. PubMed ID: 24026139
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
Lv X; Feng L; Ge X; Lu K; Wang X
J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL.
Wang W; Wang J; Li Z; Zhu M; Zhang Z; Wang Y; Jing H
Oncol Rep; 2016 Jan; 35(1):139-46. PubMed ID: 26498513
[TBL] [Abstract][Full Text] [Related]
5. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
[TBL] [Abstract][Full Text] [Related]
8. Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.
Jin Z; Qing K; Ouyang Y; Liu Z; Wang W; Li X; Xu Z; Li J
J Exp Clin Cancer Res; 2016 Mar; 35():52. PubMed ID: 27009084
[TBL] [Abstract][Full Text] [Related]
9. Z-VRPR-FMK can inhibit the growth and invasiveness of diffuse large B-cell lymphoma by depressing NF-κB activation and MMP expression induced by MALT1.
Feng J; Yang W; Wang J; Pu Z; Han Y; Wan L
Int J Clin Exp Pathol; 2019; 12(6):1947-1955. PubMed ID: 31934017
[TBL] [Abstract][Full Text] [Related]
10. [Effects of AKT protein kinase activation on biologic behavior of diffuse large B cell lymphoma cells].
Zhang TC; Zhou XY; Yu BH; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 May; 36(5):318-23. PubMed ID: 17706139
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
Liu F; Zhang Y; Tang H; Zhou X; Wu Z; Tang D; Zhao T
Oncol Rep; 2013 Aug; 30(2):783-92. PubMed ID: 23743627
[TBL] [Abstract][Full Text] [Related]
12. PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells.
Han S; Tie X; Meng L; Wang Y; Wu A
PLoS One; 2013; 8(10):e76717. PubMed ID: 24130787
[TBL] [Abstract][Full Text] [Related]
13. DSF/Cu induces antitumor effect against diffuse large B-cell lymphoma through suppressing NF-κB/BCL6 pathways.
Zhu Y; Lei C; Jiang Q; Yu Q; Qiu L
Cancer Cell Int; 2022 Jul; 22(1):236. PubMed ID: 35883106
[TBL] [Abstract][Full Text] [Related]
14. Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta.
Afrasiabi E; Ahlgren J; Bergelin N; Törnquist K
Mol Cell Endocrinol; 2008 Sep; 292(1-2):26-35. PubMed ID: 18541361
[TBL] [Abstract][Full Text] [Related]
15. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
[TBL] [Abstract][Full Text] [Related]
16. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
[TBL] [Abstract][Full Text] [Related]
17. Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosis.
Noori S; Hassan ZM
Free Radic Biol Med; 2012 May; 52(9):1987-99. PubMed ID: 22366652
[TBL] [Abstract][Full Text] [Related]
18. METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
Feng L; Yan Q; Pan H; Shi W
Immun Inflamm Dis; 2023 Feb; 11(2):e789. PubMed ID: 36840486
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.
Nagel D; Spranger S; Vincendeau M; Grau M; Raffegerst S; Kloo B; Hlahla D; Neuenschwander M; Peter von Kries J; Hadian K; Dörken B; Lenz P; Lenz G; Schendel DJ; Krappmann D
Cancer Cell; 2012 Dec; 22(6):825-37. PubMed ID: 23238017
[TBL] [Abstract][Full Text] [Related]
20. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
